Healthy adult
Conditions
Sponsors
HUMA R&D CORP
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Age: 50 and over, below 70 2)Sex: Males and females with Japanese nationality 3)Persons who are aware of a decline in cognitive functions
Exclusion criteria
Exclusion criteria: 1)Currently in treatment with medication or currently seeing a doctor for treatment 2)Previous history of hepatic disorder, severe kidney, endocrine, cardiovascular, gastrointestinal, pulmonary, hematological, or metabolic disorder, or a complication of these. 3)Previous history of drug allergy or food allergy 4)Current intake of a health food product or supplements with a possible influence on the cognitive functions 5)Current administration of medication with a possible influence on the cognitive functions 6)Extreme faddiness 7)Extremely irregular lifestyle habits such as eating and sleeping habits 8)Suspected insomnia 9)Presence or previous history of mental disorder (depression, etc.) 10)Presence or previous history of alcoholism 11)Current participation in any other clinical study or participation in other clinical study in the past three months 12)Night shifts or irregular work schedule 13)Determined by the investigator to be unsuitable for enrollment in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement effects of Cognitrax on brain functions | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood concentration of BDNF, blood concentration of inflammatory cytokines(TNF-,IL-6,IL-1), BAP levels and d-ROMs in blood, urinary 8-0HdG, and isoprostane in urine | — |
Countries
Japan
Contacts
Public ContactOchitani Daisuke
HUMA R&D CORP Clinical Development Division
Outcome results
None listed